What is the MammoSite® Radiation Therapy System (RTS)?
The MammoSite® Radiation Therapy System (RTS) is a tumor site-specific internal radiation therapy system for breast cancer. The device is comprised of a balloon catheter that internally administers the prescribed dose of radiation to targeted breast tissue in a one- to five-day course of therapy. By internally delivering radiation directly to the tissue surrounding the original tumor, the MammoSite® RTS minimizes exposure to the rest of the breast, skin, ribs, lungs and heart. The MammoSite® RTS was cleared for use by the U.S. Food and Drug Administration (FDA) in May 2002.
